Insulin attenuates the systemic inflammatory response in endotoxemic rats.

Insulin decreases the mortality and prevents the incidence of infection and sepsis in critically ill patients. The molecular and cellular mechanisms by which insulin improves survival have not been defined. The purpose of the present study was to determine the effect of insulin on the inflammatory reaction during endotoxemia. Endotoxemic rats were randomly divided into two groups to receive either saline or insulin. The effects of insulin on hepatic signal transcription factor mRNA expression, proinflammatory and antiinflammatory cytokine mRNA and protein concentration were determined. Insulin administration did not change glucose or electrolyte levels, but significantly decreased proinflammatory signal transcription factors [CCAAT/enhancer-binding protein-beta, signal transducer and activator of transcription-3 and-5, RANTES (regulated on activation, normal T cell expressed and secreted)] and cytokine expression in the liver and serum levels of IL-1beta, IL-6, macrophage inflammatory factor, and TNFalpha. Insulin administration further decreased high mobility group 1 protein in the serum compared with controls. In addition, insulin increased antiinflammatory cytokine expression in the liver; serum levels of IL-2, IL-4, and IL-10; and hepatic suppressor of cytokine signaling-3 mRNA expression. Insulin modulates the inflammatory response by decreasing the proinflammatory and increasing the antiinflammatory cascade. Because glucose and electrolyte levels did not differ between insulin-treated patients and controls, we hypothesize that the effects are direct antiinflammatory mechanisms of insulin, rather than indirect, through modulation of glucose or electrolyte metabolism.

[1]  Dagmar Klein,et al.  Insulin Treatment Improves the Systemic Inflammatory Reaction to Severe Trauma , 2004, Annals of surgery.

[2]  P. Marik,et al.  Stress-hyperglycemia, insulin and immunomodulation in sepsis , 2004, Intensive Care Medicine.

[3]  R. Einspanier,et al.  Differences in the Hepatic Signal Transcription Pathway and Cytokine Expression Between Thermal Injury and Sepsis , 2003, Shock.

[4]  R. Einspanier,et al.  Insulin Attenuates the Systemic Inflammatory Response to Thermal Trauma , 2002, Molecular medicine.

[5]  R. Barrow,et al.  IGF-I/IGFBP-3 Equilibrates Ratios of Pro- to Anti-inflammatory Cytokines, Which Are Predictors for Organ Function in Severely Burned Pediatric Patients , 2002, Molecular medicine.

[6]  A. Gelb,et al.  Propofol Anesthesia Compared to Awake Reduces Infarct Size in Rats , 2002, Anesthesiology.

[7]  B A Mizock,et al.  Alterations in fuel metabolism in critical illness: hyperglycaemia. , 2001, Best practice & research. Clinical endocrinology & metabolism.

[8]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[9]  W. Alexander,et al.  The suppressors of cytokine signalling (SOCS) , 2001, Cellular and Molecular Life Sciences CMLS.

[10]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[11]  C. Bradley Activated protein C in severe sepsis. , 2001, Intensive & critical care nursing.

[12]  M. Manns,et al.  Interleukin-6-induced Tethering of STAT3 to the LAP/C/EBPβ Promoter Suggests a New Mechanism of Transcriptional Regulation by STAT3* , 2001, The Journal of Biological Chemistry.

[13]  R. Little,et al.  Insulin resistance and substrate utilization in human endotoxemia. , 2000, The Journal of clinical endocrinology and metabolism.

[14]  N. Nicola,et al.  The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action. , 2000, Experimental hematology.

[15]  C. Ogle,et al.  The effect of burn injury on suppressors of cytokine signalling. , 2000, Shock.

[16]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[17]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[18]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[19]  C. Ogle,et al.  The Effect of Burn Injury on Suppressors of Cytokine Signalling (SOCS-2 and SOCS-3): 16 , 2000 .

[20]  N R Webster,et al.  Increased mortality associated with growth hormone treatment in critically ill adults. , 1999, The New England journal of medicine.

[21]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[22]  T. Yamashita,et al.  Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. , 1999, Critical care medicine.

[23]  M. Manns,et al.  C/EBP-β/LAP Controls Down-regulation of Albumin Gene Transcription during Liver Regeneration* , 1996, The Journal of Biological Chemistry.

[24]  D. Herndon,et al.  Effect of thermal injury on the expression of transcription factors that regulate acute phase response genes: The response of C/EBPα, C/EBPβ, and C/EBPδ to thermal injury , 1996 .

[25]  R. Wolfe,et al.  TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. , 1996, The American journal of physiology.

[26]  H. Reber,et al.  Cytokines and acute pancreatitis. , 1996, Gastroenterology.

[27]  L. Moldawer,et al.  INTERLEUKIN‐1 AND INTERLEUKIN‐1 ANTAGONISM IN SEPSIS, SYSTEMIC INFLAMMATORY RESPONSE SYNDROME, AND SEPTIC SHOCK , 1995, Shock.

[28]  C. Dinarello,et al.  The interleuldn-1 family: 10 years of discovery’ , 2004 .

[29]  A. Krensky,et al.  Genomic organization and transcriptional regulation of the RANTES chemokine gene. , 1993, Journal of immunology.

[30]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[31]  J. Norton,et al.  A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice , 1991, The Journal of experimental medicine.

[32]  C. Lang,et al.  Gram-negative infection increases noninsulin-mediated glucose disposal. , 1991, Endocrinology.

[33]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[34]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[35]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[36]  M. Lange,et al.  The relationship of insulin production to glucose metabolism in severe sepsis. , 1985, Archives of surgery.

[37]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.

[38]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[39]  M. Rennie,et al.  Muscle protein turnover and the wasting due to injury and disease. , 1985, British medical bulletin.